CR10685A - Proceso para estabilizaciuon de famotidina - Google Patents
Proceso para estabilizaciuon de famotidinaInfo
- Publication number
- CR10685A CR10685A CR10685A CR10685A CR10685A CR 10685 A CR10685 A CR 10685A CR 10685 A CR10685 A CR 10685A CR 10685 A CR10685 A CR 10685A CR 10685 A CR10685 A CR 10685A
- Authority
- CR
- Costa Rica
- Prior art keywords
- famotidine
- stabilization process
- stabilization
- famotidine stabilization
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA06010972A MXPA06010972A (es) | 2006-09-25 | 2006-09-25 | Proceso para estabilizacion de famotidina. |
Publications (1)
Publication Number | Publication Date |
---|---|
CR10685A true CR10685A (es) | 2009-05-22 |
Family
ID=39230698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR10685A CR10685A (es) | 2006-09-25 | 2009-03-24 | Proceso para estabilizaciuon de famotidina |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2085079A2 (es) |
AR (1) | AR062987A1 (es) |
BR (1) | BRPI0717425A2 (es) |
CL (1) | CL2007002760A1 (es) |
CO (1) | CO6160290A2 (es) |
CR (1) | CR10685A (es) |
MX (1) | MXPA06010972A (es) |
WO (1) | WO2008039052A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX351059B (es) * | 2012-08-17 | 2017-09-29 | Laboratorios Senosiain S A De C V Star | Composicion farmaceutica oral en forma de microesferas y proceso de elaboracion. |
DK3534880T3 (da) * | 2016-11-01 | 2022-07-25 | Johnson & Johnson Consumer Inc | Flydende oral farmaceutisk dosisform omfattende en histamin-h2-receptor-antagonist og et syreneutraliserende middel |
KR102648960B1 (ko) * | 2017-09-29 | 2024-03-20 | 존슨 앤드 존슨 컨수머 인코포레이티드 | 고체 시메티콘 입자 및 이의 투여 형태 |
CN112020350A (zh) | 2018-04-27 | 2020-12-01 | 强生消费者公司 | 液体口服药物剂型 |
CA3112541A1 (en) | 2018-10-18 | 2020-04-23 | Johnson & Johnson Consumer Inc. | Novel dosage form |
AU2020353342A1 (en) * | 2019-09-27 | 2022-05-19 | Johnson & Johnson Consumer Inc. | Gel-chewable dosage form |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2235368T3 (es) * | 1997-10-27 | 2005-07-01 | Sumitomo Pharmaceuticals Company, Limited | Derivados de amida para tratar alteraciones neurodegenerativas de la retina. |
US20050053655A1 (en) * | 2003-09-05 | 2005-03-10 | Pharmaceutical Industry Technology And Development Center | Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same |
-
2006
- 2006-09-25 MX MXPA06010972A patent/MXPA06010972A/es not_active Application Discontinuation
-
2007
- 2007-09-24 EP EP07834489A patent/EP2085079A2/en not_active Withdrawn
- 2007-09-24 WO PCT/MX2007/000108 patent/WO2008039052A2/es active Application Filing
- 2007-09-24 BR BRPI0717425-0A patent/BRPI0717425A2/pt not_active Application Discontinuation
- 2007-09-25 AR ARP070104238A patent/AR062987A1/es not_active Application Discontinuation
- 2007-09-25 CL CL200702760A patent/CL2007002760A1/es unknown
-
2009
- 2009-03-24 CR CR10685A patent/CR10685A/es not_active Application Discontinuation
- 2009-03-25 CO CO09030530A patent/CO6160290A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO6160290A2 (es) | 2010-05-20 |
MXPA06010972A (es) | 2009-04-17 |
CL2007002760A1 (es) | 2008-04-25 |
BRPI0717425A2 (pt) | 2013-11-12 |
WO2008039052A8 (es) | 2009-05-07 |
AR062987A1 (es) | 2008-12-17 |
WO2008039052A3 (es) | 2008-06-19 |
WO2008039052A2 (es) | 2008-04-03 |
EP2085079A2 (en) | 2009-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2008009972A (es) | Composición estabilizante para polímeros | |
BRPI0818546A2 (pt) | Misturas de enzimas para fermentação | |
DK3354267T3 (da) | Stabiliseret sulforaphan | |
DE602007012130D1 (de) | Modifizierte flavin-adenin-dinucleotid-abhängige glucose-dehydrogenase | |
BRPI0716528A2 (pt) | mÉtodo de estabilizaÇço | |
DOS2008000026S (es) | Confiteria | |
FI20060795A (fi) | Kylläisyyttä aiheuttava tuote | |
BRPI0815550A2 (pt) | Método para estabilizar fenilefrina | |
BRPI0813670A2 (pt) | Compostos para tratamento | |
DE502007004064D1 (de) | Querträger | |
BRPI0923401A2 (pt) | Métodos para o preparo de aril amidas. | |
SE0801651L (sv) | Granuleringskvarn | |
FI20060141A (fi) | Viiluleikkuri | |
LU93092I2 (de) | Alemtuzumab | |
CR10685A (es) | Proceso para estabilizaciuon de famotidina | |
BRPI0816288A2 (pt) | Processos e compostos | |
BRPI0812105A2 (pt) | Neramexano para o tratamento de nistagmo | |
DK2089708T3 (da) | Forudsigelige kræft-immunterapi parametre | |
ES1063735Y (es) | Testero para persiana | |
ES1062737Y (es) | Bastidor para aperos agricolas | |
ES1065835Y (es) | Caperuza para cetreria | |
DE112007003228A5 (de) | Temperiervorrichtung | |
ES1063779Y (es) | Pallon para gaitas | |
ES1062323Y (es) | Molde-plantilla para deshidratadores de alimentos | |
UA15700S (uk) | Печиво |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |